RespireRx Pharmaceuticals Inc. Announces Data for CX1739 Clinical Study in Opioid Induced Respiratory Depression

GLEN ROCK, NJ — (Marketwired) — 12/15/16 — RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the…

Continue Reading